Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC) Meeting Abstract
| Authors: | Matulonis, U.; Wulf, G. M.; Birrer, M. J.; Westin, S. N.; Quy, P.; Bell-Mcguinn, K. M.; Lasonde, B.; Whalen, C.; Aghajanian, C.; Solit, D. B.; Mills, G. B.; Cantley, L.; Winer, E. P. |
| Abstract Title: | Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202775 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.2510 |
| Notes: | Meeting Abstract: 2510 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
779Solit -
607Aghajanian -
60Bell-McGuinn
Related MSK Work